Original Research
Accepted on 19 Sep 2025
Switching from Febuxostat to Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, may Substantially Reduce Serum Urate Levels, through URAT1 Inhibition, Potentially without Adversely Affecting ABCG2 Function: Findings from the SWITCH SURI study
in Renal Endocrinology
- 159 views